Skip to content

Clinical trials

Hepatitis C, Chronic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: Australia Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20051
20061
20074
20085
20092
20105
201110
201211
20135
20141
20152
20163
20172
20181
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated4
Unknown status3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche12
Kirby Institute10
Gilead Sciences8
Boehringer Ingelheim4
AbbVie3
Debiopharm International SA3
GlaxoSmithKline3
Human Genome Sciences Inc.3
Novartis Pharmaceuticals2
AbbVie (prior sponsor, Abbott)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic62
Hepatitis C26
Hepatitis4
Acquired Immunodeficiency Syndrome1
Fibrosis1
Hepatitis, Chronic1
Infections1
Liver Diseases1
Reinfection1
Virus Diseases1

Trials

Showing 76 to 62 of 62. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.